Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bristol Myers Squibb India Private Limited is the Indian subsidiary of the global biopharmaceutical giant Bristol Myers Squibb. Established in 2004 and headquartered in Mumbai, the company focuses on delivering innovative medicines in key therapeutic areas, including oncology, hematology, immunology, and cardiovascular health. Its commercial portfolio in India features advanced therapies such as Opdyta (nivolumab), Rojuzda (luspatercept), Kopozgo (mavacamten), and Yervoi (ipilimumab). Beyond commercial operations, the company has a significant footprint in India, including the Biocon Bristol Myers Squibb Research & Development Center (BBRC) in Bangalore and a major Global Capability Center in Hyderabad that supports global drug development, digital innovation, and business insights.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bristol Myers Squibb India.